Copy number assessment in the genomic analysis of CNS neoplasia: An evidence-based review from the cancer genomics consortium (CGC) working group on primary CNS tumors.

MLA

Neill, Stewart G., et al. “Copy Number Assessment in the Genomic Analysis of CNS Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium (CGC) Working Group on Primary CNS Tumors.” Cancer Genetics, vol. 243, May 2020, pp. 19–47. EBSCOhost, https://doi.org/10.1016/j.cancergen.2020.02.004.

APA

Neill, S. G., Hauenstein, J., Li, M. M., Liu, Y. J., Luo, M., Saxe, D. F., & Ligon, A. H. (2020). Copy number assessment in the genomic analysis of CNS neoplasia: An evidence-based review from the cancer genomics consortium (CGC) working group on primary CNS tumors. Cancer Genetics, 243, 19–47. https://doi.org/10.1016/j.cancergen.2020.02.004

Chicago

Neill, Stewart G., Jennifer Hauenstein, Marilyn M. Li, Yajuan J Liu, Minjie Luo, Debra F. Saxe, and Azra H. Ligon. 2020. “Copy Number Assessment in the Genomic Analysis of CNS Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium (CGC) Working Group on Primary CNS Tumors.” Cancer Genetics 243 (May): 19–47. doi:10.1016/j.cancergen.2020.02.004.